STONY BROOK, N.Y.--(BUSINESS WIRE)--July 11, 2005--Infrared Sciences Corporation (ISC) announced today that they have commenced a Clinical Study with the New York Presbyterian Hospital-Weill Medical College of Cornell University in New York City. The protocol will focus on determining the adjunctive effectiveness of the Infrared Sciences Sentinel BreastScan imaging system for early breast cancer detection. Study patients will have been scheduled for a breast biopsy, either by mammography or ultrasound. The Study will correlate the outcomes of radiology, pathology, and the Sentinel BreastScan. “We are pleased and excited to commence this study with Cornell, and we believe that the information obtained from the Sentinel system will prove it to be a highly effective adjunctive tool in the war against breast cancer” explained ISC Vice President, Matthew Campisi. “The Sentinel system provides a new physiological dimension to breast health information that is not available from any other fully non-invasive testing method.”
